{"id":"W4286562026","doi":"10.1038/s41375-022-01637-7","title":"Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis","year":2022,"lang":"en","type":"article","venue":"Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Sierra Oncology","keywords":"Ruxolitinib; Myelofibrosis; Internal medicine; Medicine; Anemia; Phases of clinical research; Survival analysis; Clinical trial; Randomized controlled trial; Gastroenterology; Oncology; Bone marrow","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002490218,0.0003554444,0.0008559708,0.0003411215,0.0001855398,0.0005327516,0.0002060846,0.0003233092,0.000991376],"category_scores_gemma":[0.001568186,0.0001238489,0.001288868,0.0003163069,0.0002222457,0.0003886212,0.0004803023,0.0007247014,0.00009999504],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000417531,"about_ca_system_score_gemma":0.0004353315,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004510984,"about_ca_topic_score_gemma":0.00196656,"domain_scores_codex":[0.9993656,0.0003109488,0.00003974856,0.0001028193,0.00009915561,0.00008167464],"domain_scores_gemma":[0.9993026,0.0001913164,0.0002346233,0.00007756464,0.00004552933,0.000148297],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3785586,0.002542204,0.2770157,0.0009325436,0.004643871,0.0004347951,0.0003072318,0.009994833,0.01613975,0.001409605,0.01497722,0.2930436],"study_design_scores_gemma":[0.04585585,0.07252531,0.8490029,0.0001665262,0.004888719,0.0008882203,0.0001335713,0.007863093,0.004866505,0.001539664,0.01219076,0.00007893519],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912158,0.004788315,0.0003774787,0.0003565288,0.00005772173,0.00006772227,0.000818093,0.00003316118,0.002285292],"genre_scores_gemma":[0.9945575,0.001125288,0.0002627474,0.0003344666,0.0001215396,0.00006490757,0.002864089,0.000005996878,0.0006635389],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002490218,"threshold_uncertainty_score":0.01316971,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03080531124568245,"score_gpt":0.3067301174061303,"score_spread":0.2759248061604478,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}